Qiagen N.V. (QGEN) SEC Filings — 2024

Filings

• QIAGEN N.V. Reports Change in Certifying Accountant — 6-K · Nov 8, 2024
• Qiagen N.V. SC 13G Filing — SC 13G · Nov 8, 2024
• Qiagen N.V. SC 13G Filing — SC 13G · Nov 7, 2024
• Qiagen N.V. SC 13G Filing — SC 13G · Oct 21, 2024
• QIAGEN Finalizes Convertible Bond Offering Terms — 6-K · Sep 4, 2024
• QIAGEN Proposes $450M Convertible Bond Offering — 6-K · Sep 3, 2024
• QIAGEN N.V. Files 6-K on Annual Shareholder Meeting — 6-K · Aug 2, 2024
• QIAGEN N.V. Holds Capital Markets Day — 6-K · Jun 24, 2024
• QIAGEN Discontinues NeuMoDx Molecular Systems — 6-K · Jun 6, 2024
• QIAGEN N.V. Files Q1 2024 6-K Report — 6-K · May 1, 2024
• QIAGEN N.V. Files 20-F Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 11, 2024
• MFS Boosts QIAGEN Stake to 20.45M Shares, Signals Confidence — SC 13G/A · Feb 9, 2024
• QIAGEN Files 6-K, Reports Unaudited Q4 & FY 2023 Results — 6-K · Feb 8, 2024
• BlackRock Amends QIAGEN N.V. Stake, Maintains Passive Position — SC 13G/A · Jan 23, 2024
• QIAGEN Details $300M Synthetic Share Buyback Plan — 6-K · Jan 23, 2024
• QIAGEN to Return $300M to Shareholders via Synthetic Buyback — 6-K · Jan 8, 2024